Understanding Adolescent Parenthood From a Multisystemic Perspective
Abstract
Purpose
This study examined the associations between social, behavioral, and environmental factors and adolescent parenthood.
Methods
We analyzed data from a subsample of participants, 18–30 years of age (n
=
7,937), who took part in the 2001–2002 National Epidemiologic Study on Alcohol and Related Conditions, a nationally representative survey of adults. An extended Cox proportional hazards model was used to model time until becoming an adolescent parent (i.e., age at which first child was born if ≤18 years). Predictor variables of interest included initiation of alcohol, marijuana, cocaine, and daily cigarette use, age of earliest conduct disorder symptom, having a parent with alcohol and/or drug problems, parental death, divorce and/or separation, race/ethnicity, and gender.
Results
Several variables were associated with adolescent parenthood, including initiation of daily cigarette smoking, age of first antisocial/conduct disorder symptom, and race/ethnicity. Parental alcohol/drug problems and parental death were also associated with adolescent parenthood for women. A significant interaction between initiation of daily cigarette smoking and ethnicity was present for women. Daily cigarette smoking was associated with adolescent parenthood to a greater degree than nondaily cigarette smoking for white and Hispanic women but not African American women. No significant associations were found between adolescent parenthood and initiation of drinking, marijuana, or cocaine and parental divorce/separation.
Conclusions
Prevention efforts should focus on adolescents who are at highest risk of adolescent parenthood.
Keywords: Adolescent parenthood, Substance use, Adolescent health, Sexuality education
To access this article, please choose from the options below
Disclaimer: Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.
Dr. Bierut is listed as an inventor on a patent (US 20070258898) held by Perlegen Sciences, Inc., covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. Dr. Bierut has acted as a consultant for Pfizer, Inc. in 2008. All remaining authors do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as real or apparent conflict of interest in the context of the subject of this article.
PII: S1054-139X(09)00633-8
doi:10.1016/j.jadohealth.2009.11.209
© 2010 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
